California Court Signals Limits on “Duty to Innovate” in Gilead HIV Case
California’s highest court is weighing a case that could reshape how far pharmaceutical companies are expected to go in developing improved medicines, with early signals suggesting caution around imposing a legal “duty to innovate.”
